| Previous close | 20.90 |
| Open | 20.90 |
| Bid | 43.00 |
| Ask | 47.70 |
| Strike | 280.00 |
| Expiry date | 2024-01-19 |
| Day's range | 20.90 - 20.90 |
| Contract range | N/A |
| Volume | |
| Open interest | 47 |
Simply Wall St.Just Four Days Till Becton, Dickinson and Company (NYSE:BDX) Will Be Trading Ex-Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
- Reuters
UPDATE 2-US FDA says BD recalling infusion pumps due to compatibility issues
The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's Monoject syringes. The health regulator said Alaris pumps are validated for use with Monoject syringes.
PR NewswireFDA Safety Communication Does Not Impact BD Syringes
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Safety Communication on evaluation of certain plastic syringes:
© 2023 Yahoo. All rights reserved.